首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Regulation of protein synthesis: Activation by double-stranded RNA of a protein kinase that phosphorylates eukaryotic initiation factor 2
【2h】

Regulation of protein synthesis: Activation by double-stranded RNA of a protein kinase that phosphorylates eukaryotic initiation factor 2

机译:蛋白质合成的调控:磷酸化真核生物起始因子2的蛋白激酶的双链RNA激活。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Incubation of reticulocyte lysates or isolated crude ribosomes with low levels of double-stranded RNA (0.1-10 ng/ml) induces the formation of an inhibitor of protein synthesis initiation similar to that observed in heme deficiency. The inhibitor is associated with a cyclic AMP-independent protein kinase activity (ATP:protein phosphotransferase, EC 2.7.1.37) that phosphorylates the small polypeptide (38,000 daltons) of the eukaryotic initiation factor eIF-2. Activation of the inhibitor requires ATP in addition to double-stranded RNA and is accompanied by the phosphorylation of a 67,000-dalton polypeptide of unknown function. The inhibitor remains associated with the ribosomes during high-speed sedimentation. Once formed, the ribosome-associated inhibitor phosphorylates eIF-2 and inhibits protein synthesis in the absence of double-stranded RNA. Inhibition is prevented by exogenous eIF-2. The bound inhibitor can be solubilized by extraction with 0.5 M KCl. The soluble inhibitor preparation retains the ability to phosphorylate the small polypeptide of eIF-2 and to inhibit protein synthesis. Untreated crude ribosomes also contain cyclic AMP-independent protein kinase activities that phosphorylate the middle polypeptide (49,000 daltons) of eIF-2 and several polypeptide subunits of eIF-3 (160,000, 125,000, and 65,000 daltons); these kinase activities are not affected by double-stranded RNA and do not inhibit protein synthesis.
机译:将网状细胞裂解物或分离的粗核糖体与低水平的双链RNA(0.1-10 ng / ml)一起孵育可诱导形成类似于血红素缺乏症的蛋白质合成抑制剂。该抑制剂与不依赖于AMP的环状蛋白激酶活性(ATP:蛋白磷酸转移酶,EC 2.7.1.37)相关,该活性使真核生物起始因子eIF-2的小多肽(38,000道尔顿)磷酸化。抑制剂的激活除双链RNA外还需要ATP,并伴有功能未知的67,000道尔顿多肽的磷酸化。在高速沉降过程中,抑制剂仍与核糖体结合。一旦形成,与核糖体相关的抑制剂会在没有双链RNA的情况下磷酸化eIF-2并抑制蛋白质合成。外源性eIF-2阻止了这种抑制作用。结合的抑制剂可以通过用0.5M KCl萃取来溶解。可溶性抑制剂制剂保留了磷酸化eIF-2小多肽和抑制蛋白质合成的能力。未经处理的粗核糖体还具有不依赖环AMP的蛋白激酶活性,这些活性使eIF-2的中间多肽(49,000道尔顿)和eIF-3的几个多肽亚基(160,000、125,000和65,000道尔顿)磷酸化;这些激酶活性不受双链RNA的影响,并且不抑制蛋白质的合成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号